期刊文献+

大鼠肝细胞液体外甲基化代谢丹酚酸A的酶促反应动力学 被引量:2

Enzyme kinetic studies on in vitro methylation metabolism of salvianolic acid A by rat liver cytosol
下载PDF
导出
摘要 目的筛选大鼠肝细胞液作为儿茶酚-O-甲基转移酶(COMT)供体,建立丹酚酸A(SAA)体外孵育甲基化代谢的酶促反应。方法采用HPLC-UV法检测孵育体系中底物SAA的浓度,根据底物消耗量计算SAA的体外酶促代谢反应速度和动力学参数。结果在大鼠肝细胞液体外温孵体系中,SAA的酶促甲基化代谢反应呈现饱和动力学特征,符合Michaelis-Menten曲线,最大反应速率(Vmax)和米氏常数(Km)分别为30.4 nmol·mol-1·min-1,0.179 mmol·L-1。结论大鼠肝脏的COMT酶对SAA有较强的亲和力,可催化SAA发生快速、完全的甲基化代谢,大鼠肝细胞液与SAA在控制条件下体外温孵是高收率、选择性制备SAA甲基化代谢产物的一种有效手段。 Objective In the present study, rat liver cytosol was selected as donor of eatechol - O - methyhransferase (COMT) to develop an incubation system for in vitro enzyme - catalyzed methylation metabolism of SAA. Methods The contents of unmetabolized SAA left in the incubation system were determined by specific and reliable HPLC - UV assay. According to the substrate consumption, the enzyme reaction rate was calculated and the enzyme kinetic analysis of the reaction was conducted. Results Under the optimal in vitro incubation conditions, the metabolic elimination of SAA fit in with Michaelis - Menten curve and the maximum reaction rate (Vmax) was revealed as 30.4nmol·mol^-1·min^-1,0.179mmol·L^-1 with a Km value of 0. 179 mmol·L^-1. Conclusion These results indicated that COMT in rat liver has fairly high affinity for SAA and this polyphenol compound may undergo remarkable first - pass metabolism in vivo. The present study also suggested that in vitro incubation with rat liver cytosol would be a satisfactory biochemical pathway to obtain methylation metabolites of SAA with high yield and selectivity.
机构地区 烟台大学药学院
出处 《时珍国医国药》 CAS CSCD 北大核心 2013年第9期2061-2063,共3页 Lishizhen Medicine and Materia Medica Research
基金 国家自然科学基金(No.81102780)
关键词 丹酚酸A 甲基化代谢 大鼠肝细胞液 酶促反应动力学 Salvianolie acid A Methylation metabolism Rat liver cytoehylema Enzyme kinetics
  • 相关文献

参考文献12

  • 1Liu GT, Zhang TM, Wang BE, et al. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes [ J ]. Biochem Pharmacol, 1992,43 : 147.
  • 2Fan HY, Fu FH, Yang MY, et al. Antiplatelet and antithrombotic activi- ties of salvianolic acid A[ J]. Thromb Res,2010,126 :e17.
  • 3Fan HY, Yang L, Fu FH, et al. Cardioproteetive effects of salvianolie acid A on myocardial isehemia reperfusion injury in vivo and in vitro [ J]. Evid Based Complement Aiternat Med,2012:508938.
  • 4Hou YY,Peng JM, Chao RB. Pharmacokinetic study of salvianolic acid A in rat after intravenous administration of Danshen injection [ J ]. Bi- omed Chromatogr,2007,21 (6) :598.
  • 5Shen Y, Wang XY, Xu LH, et al. Characterization of metabolites in rat plasma after intravenous administration of salvianolic acid A by liquid chromatography/time -of- flight mass spectrometry and liquid chroma- tography/ion trap mass spectrometry [ J ]. Rapid Commun Mass Spec- trom,2009,23 (12) : 1810.
  • 6邹晓丽.丹酚酸A的临床前药代动力学研究[D].烟台:烟台大学硕士学位论文,2011:74.
  • 7杨丽娜,肖盛元,邓玉林.RP-HPLC法测定鼠肝组织儿茶酚氧位甲基转移酶活性的研究[J].现代科学仪器,2009,26(1):59-61. 被引量:3
  • 8Elovaara E, Mikkola J, Luukkanen L, et al. Assessment of catechol in- duction and glncuronidation in rat liver microsomes [ J ]. Drug Metab Dispos ,2004,32 ( 12 ) : 1426.
  • 9Mannisto PT, Kaakkola S. Cateeho! - O - methyltransferase (COMT) : biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors [ J ]. Pharmaeo Rev, 1999,51 ( 4 ) : 593.
  • 10Dawling S, Roodi N, Mernaugh RL, et al. Catechol - 0 - methyltrans- ferase (COMT) - mediated metabolism of catechol estrogens:compari- son of wild - type and variant COMT isoforms [ J ]. Cancer Res,2011,61 (18) :6716.

二级参考文献10

  • 1姜红燕,许秀峰.精神分裂症与儿茶酚氧位甲基转移酶基因多态性[J].国外医学(遗传学分册),2005,28(5):309-312. 被引量:6
  • 2Carola Tilgmann, Is mo Ulmanen. Purification methods of mammalian catechol - O - methyltrans - ferases. J Chromatogr B, 1996. 684 : 147 -161
  • 3Tetsuro Kondo, Takashi Tominagal, Michinori Ichikawa, Toshio lijima. Differential alteration of hippocampal synaptic strength induced by pituitary adenylate cyclase activating polypeptide - 38 ( PACAP - 38 ). Neurosci Lett, 1997,221:189 - 192
  • 4Erkki Nissinen. Determination of catechol - O - methyltransferase activity in brain tissue by high - performanceliquid chromatography with on- line radiochemical detection. Anal Biochem, 1985, 144:247 - 252
  • 5N. P. M. Smit, S. Pavel, A. Kammeyer, W. Westerhof. Determination of catechol - O - methyhransfe - rase activity in relation to melanin metabolism using high - performance liquid chromatography with fluorimetric detection. Anal Biochem, 1990,190:286 - 291
  • 6Todd Ellingson, Sushil Duddempudi, Benjamin D. Greenberg, et al. Determination of differential activities of soluble and membranebound catechol - O - methyhransferase in tissues and erythrocytes. J Chromatogr B, 1999. 729:347 - 353
  • 7Pekka T, Seppo K. Catechol-O-methyltransferase (COMT) : biochemistry,molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors[J]. Pharmacological review, 1999,51 (4) :593-628.
  • 8Zhu BT. Catechol-O-Methytransferase(COMT) mediated methylation metabolism of endogenous bioactive catechols and modula tion by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis[J]. Current Drug Metabolism,2002,3 321-349.
  • 9Eija S, Erkki N. Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection[J]. Biomedical chromatography, 1989,3 (2) : 64-67.
  • 10Paivi T, Ilkka R, Pekka T, et al. Validation of assay of catechol-O-methyltransferase activity in human erythrocytes[J]. Journal of Pharmaceutical and Biomedical Analysis, 1996, 14: 515-523.

共引文献3

同被引文献20

  • 1Liu GT, Zhang TM, Wang BE, et al. Protective action of seven natu- ral phenolic compounds against peroxidative damage to biomembranes [J]. Biochem Pharmaco, 1992, 43: 147-152.
  • 2Fan HY, Fu FH, Yang MY, et al. Antiplatelet and antithrombotic activities of salvianolic acid A[J]. Thromb Res, 2010, 126: e17-e22.
  • 3Fan HY, Yang L, Fu FH, et al. Cardioprotective effects of salvianolic acid A on myocardial ischemia reperfusion injury in vivo and in vitro[J]. eCAM, 2012, d0i:10.1155/2012/508938.
  • 4Hou YY, Pang JM, Chao RB. Pharmacokinetic study of salvianolic acid A in rat after intravenous administration of Danshen injection [J]. Biomed Chromatogr, 2007, 21: 598- 601.
  • 5Shen Y, Wang XY, Xu LH, et al. Characterization of metabolites in rat plasma after intravenous administration of salvianolic acid A by liq- uid chromatography/time-of-flight mass spectrometry and liquid chro- matography/ion trap mass spectrometry[J]. Rapid Commun Mass Spec- trom, 2009, 23: 1810-1816.
  • 6Xu H, Li YL, Che X, et al. Metabolism of salvianolic acid A and antioxidant activities of its methylated metabolites [J]. Drug Metab Dispos, 2014, 42(2): 274-81.
  • 7Han DE, Zheng , Chen X, et al. identification and characterization of human UDP-glucuronosy-transferases responsible for the in vitro glucuronidation of salvianolic acid A[J]. Drug Metabolism and Pharma- cokinetics, 2012, 27(6): 579-585.
  • 8Hodgson J.查看详情[J],Nature Biotechnology2001(08):722-726.
  • 9Selick H E;Beresford A P;Tarbit M H.查看详情[J],DRUG DISCOVERY TODAY2002(02):109-116.
  • 10Lu YR;FooL Y.查看详情[J],Phytochemistry2002(02):117-140.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部